adenosine 6mg/2ml solution for injection vials
advanz pharma - adenosine - solution for injection - 3mg/1ml
adenosine 30mg/10ml solution for infusion vials
advanz pharma - adenosine - solution for infusion - 3mg/1ml
adenocor
sanofi - aventis israel ltd - adenosine - solution for injection - adenosine 6 mg / 2 ml - adenosine - adenosine - rapid conversion to a normal sinus rhythm of paroxysmal supraventicular tachycardias including those associated with accessory bypass tracts (wolf parkinson-white syndrome).
adenosine triphosphate
ceva animal health pty ltd - adenosine triphosphate - unknown - adenosine triphosphate nucleotide active 0.0 - active constituent
highlights of prescribing information
teva parenteral medicines, inc. - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567) - adenosine 3 mg in 1 ml - adenosine injection is indicated as an adjunct to thallium-201 myocardial perfusion scintigraphy in patients unable to exercise adequately. adenosine is contraindicated in patients with: - second- or third-degree av block (except in patients with a functioning artificial pacemaker) [see warnings and precautions (5.2)] - sinus node disease, such as sick sinus syndrome or symptomatic bradycardia (except in patients with a functioning artificial pacemaker) [see warnings and precautions (5.2)] - known or suspected bronchoconstrictive or bronchospastic lung disease (e.g., asthma) [see warnings and precautions (5.3)] - known hypersensitivity to adenosine [see warnings and precautions (5.7)] animal reproduction studies have not been conducted with adenosine; nor have studies been performed in pregnant women. because it is not known whether adenosine can cause fetal harm when administered to pregnant women, adenosine should be used during pregnancy only if clearly needed. it is not known whether adenosine is excreted
adenosine solution for infusion 3mg
cherubino limited delf building, sliema road, gzira, gzr 1637, malta - adenosine - solution for infusion - adenosine 3 mg - cardiac therapy
adenosine 3mg/ml solution for injection
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - adenosine - solution for injection - adenosine 3 mg/ml - cardiac therapy
adenosine baxter adenosine 30 mg/10 ml solution for infusion vial
baxter healthcare pty ltd - adenosine, quantity: 30 mg - solution - excipient ingredients: sodium chloride; water for injections - intravenous adenosine (30 mg/10 ml) is a coronary vasodilator for use in conjunction with radionuclide myocardial perfusion imaging, in patients unable to exercise adequately.
adenosine injection, solution
a-s medication solutions - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567) - adenosine injection is indicated for the following. conversion to sinus rhythm of paroxysmal supraventricular tachycardia (psvt), including that associated with accessory bypass tracts (wolff-parkinson-white syndrome). when clinically advisable, appropriate vagal maneuvers (e.g., valsalva maneuver), should be attempted prior to adenosine administration. it is important to be sure the adenosine solution actually reaches the systemic circulation (see dosage and administration ). adenosine does not convert atrial flutter, atrial fibrillation, or ventricular tachycardia to normal sinus rhythm. in the presence of atrial flutter or atrial fibrillation, a transient modest slowing of ventricular response may occur immediately following adenosine administration. adenosine injection is contraindicated in: - second- or third-degree a-v block (except in patients with a functioning artificial pacemaker). - sinus node disease, such as sick sinus syndrome or symptomatic bradycardia (except in patients with a functioning art
adenosine 3mg/ml solution for injection
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - adenosine - solution for injection - adenosine 3 mg/ml - cardiac therapy